Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
7th grade Avg
|
New words:
accelerated, adecade, adjuctive, adopamine, Allen, alliance, andZoloftin, antagonistindicated, associatedwith, assumed, Ausiello, availableprimarily, Bagger, Belgiancompany, broadening, builton, Bulgaria, byreference, bythe, Canadaand, carcinoma, CelebrexandDetrol, Celebrexin, cessation, Champix, Chantix, Charter, check, choice, closure, combiningLipitorandNorvascfor, conditionally, Connolly, Deach, deficiency, delinquent, documented, dysphoricdisorder, earlier, eliminate, English, enterprise, entrepreneurial, Environmentin, epileptic, ExecutiveCompensation, fastestgrowing, fate, Feczko, filer, fim, FinancialReport, fixedcombination, forerectile, forZithromaxin, forZoloftexpired, forZyrtecin, Francisco, Frankfurt, fromZyrtecafter, Georgetown, GIST, Glaxo, glycemic, Graph, headingDirector, headingPharmaceutical, highlight, Ian, ill, imatinib, impose, includingLipitor, incombination, inDecember, Independencein, inearly, inEurope, inhibit, inJune, inmore, Insider, insulation, insulintherapy, intolerance, inworldwide, isindicated, Japanese, Johnson, Joseph, juvenilerheumatoid, knowledge, labor, legislature, leucovorin, link, Lyrica, makeup, MATTERSAND, McCarter, medicinein, mesylate, metastatic, metastaticcolorectal, metastic, migrating, Nomination, Nox, ofcardiovascular, oflabeling, ofNorvascandZyrtec, ofNorvascandZyrtecto, ofZoloftwere, onCamptosarandInspraexpire, onViagraandthe, onZithromaxin, oralcapsule, ourtotal, outsource, outstanding, OwnersandEquity, panicdisorder, par, partialonsent, Participationin, partner, Peer, PGM, pipeline, prescriptiontreatment, ProductivityunderOverview, professor, promising, prostaglandin, psychotropic, receptor, recognized, referenceFinancial, renal, resource, return, returned, Reviewsectionof, Richard, Romania, Rule, San, schizophreniaand, SECURITY, seeRegulatory, SelectedProduct, Shanghai, Shareholdersin, shell, shorter, smoking, somatropin, specialist, standardize, steep, stop, stressdisorder, stromal, surpassed, THECOMPANY, theEuropean, theExuberainsulin, theworld, toCelebrexunderthe, tracking, unfavorably, UNRESOLVED, usorour, utilization, Viagrain, VOTE, voting, Washington, waslaunched, Waxman, Wewill, whileLyrica, withGenotropin, withtype, workforce, yen, Yeso, Zoloftand
Removed:
accepted, ACE, achieve, advantage, Agreementsin, anticipate, antifungal, attack, atypical, Benadryl, benign, Boehringer, breast, broadest, bronchospasm, captionedQuarterly, captionedSegmentin, congestive, considerable, converting, COPD, dependence, dysphoric, EllenceandAromasinare, emphysema, enzyme, favorably, Geodon, gland, hair, half, heart, hyperplasia, identity, immune, influencing, Ingelheim, inMarketing, internationally, Karen, Katen, maintain, merged, nearby, nutrition, OTC, panic, partial, party, Pension, permit, pooling, Portage, problem, prostatic, pulmonary, range, represented, SAD, sellZyrtecunder, Serono, strong, systemic, tobacco, upper
Filing tables
Filing exhibits
Related press release
PFE similar filings
Filing view
External links